Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 - 8th, 2024
In: GlobeNewswire, 2024-04-24
Zeitungsartikel
Zugriff:
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the 'Company' or 'AGN Pharma') (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, [...]
Titel: |
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 - 8th, 2024
|
---|---|
Zeitschrift: | GlobeNewswire, 2024-04-24 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|